Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Robert James Wills Insider Profile
4 Followers
Robert James Wills, Director at Oncternal Therapeutics, holds 10.00K shares in Oncternal Therapeutics (Ticker: ONCT), holds 0.00 shares in CymaBay Therapeutics (Ticker: CBAY), holds 15.00K shares in Milestone Pharmaceuticals (Ticker: MIST). Most recently, Robert James Wills Bought ― shares of Oncternal Therapeutics on Apr 10, 2024 for an estimated value of 27.65K.
Robert James Wills Oncternal Therapeutics (ONCT)Director
Oncternal Therapeutics (ONCT)
Director
Ranked #84,056 out of 99,218 Corporate Insiders
Profitable Transactions
3 out of 11 Profitable Transactions
Average Return
-17.30%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Robert James Wills holds in companies
Most Profitable Insider Trade
Stock:
CymaBay Therapeutics
(CBAY)
(CBAY)
Rating:Informative Buy
Date:Sep 09, 2016 - Sep 09, 2017
Return:+155.30%
The most profitable trade made by Robert James Wills
Robert James Wills's Trading History
Oncternal Therapeutics
Apr 10, 2024
Director
Informative Buy
27.65K
$16.20K
Milestone Pharmaceuticals
Oct 21, 2022
Director
Informative Buy
73.95K
$23.85K
CymaBay Therapeutics
Mar 22, 2024
―
Uninformative Sell
―
$0.00
List of latest transactions for each holding click on a transaction to see Robert James Wills's performance on stock
You May Also Like
Robert James Wills insider profile FAQ
What is the percentage of profitable transactions made by Robert James Wills?
The percentage of profitable transactions made by Robert James Wills is 27%.
What is the average return per transaction made by Robert James Wills?
The average return per transaction made by Robert James Wills is -17.30%.
What stocks does Robert James Wills hold?
Robert James Wills holds: ONCT, MIST, CBAY stocks.
What was Robert James Wills’s latest transaction?
Robert James Wills latest transaction was an Informative Buy of $27.65K.
What was Robert James Wills's most profitable transaction?
Robert James Wills’s most profitable transaction was an Informative Buy of CBAY stock on September 9, 2016. The return on the trade was 155.30%.
What is Robert James Wills's role in Oncternal Therapeutics?
Robert James Wills's role in Oncternal Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.